Market Overview

UPDATE: Jefferies Lowers PT on Aeropostale Following Weak Q4

Related ARO
Mid-Afternoon Market Update: Dow Falls 100 Points; Sarepta Therapeutics Shares Drop Following Release of FDA Briefing Documents on Eteplirsen
Aeropostale's Stock Plunges Following Bloomberg Report Company Is Preparing To Declare Bankruptcy

Jefferies maintained Aeropostale (NYSE: ARO) with a Buy rating and lowered the price target from $18.00 to $17.00.

Jefferies analyst Randal J. Konik commented, "ARO reported a weak 4Q which was no surprise following the Holiday sales release and recently lowered guidance. Trends clearly remain challenged, but we believe expectations are now low enough for FY'14. This stock call continues to be based on the strong balance sheet ($230M cash at yr end) and cash generating properties of ARO. We see downside as limited and attractive risk/reward."

Aeropostale closed at $14.51 on Thursday.

Latest Ratings for ARO

Aug 2015Wolfe ResearchInitiates Coverage onPeer Perform
Jul 2015UBSDowngradesNeutralSell
May 2015Stephens & Co.MaintainsEqual-Weight

View More Analyst Ratings for ARO
View the Latest Analyst Ratings

Posted-In: JefferiesAnalyst Color Price Target Analyst Ratings


Related Articles (ARO)

View Comments and Join the Discussion!

Partner Center